Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

FDA Clears Varian Medical's Two Products - Quick Facts

RELATED NEWS
Trade VAR now with 

Varian Medical Systems (VAR: Quote) Thursday said it has received an FDA 510(k) clearance for the latest version of its Vitesse real time planning for HDR brachytherapy. This is used to plan and perform high-dose-rate or HDR, ultrasound-guided brachytherapy treatments for prostate cancer.

Tim Clark, marketing manager for Varian BrachyTherapy, said, "This version of Vitesse reduces the number and complexity of steps involved in planning and completing a treatment. It eliminates the need for a data transfer to another software program, and avoids moving the patient to a CT scanner for images in the middle of the procedure.''

According to him, most clinicians will see a reduction in the amount of time needed to complete these treatments, often by as much as an hour and a half.

Separately, the company said the regulator also cleared its Edge radiosurgery suite, a new dedicated system for performing advanced radiosurgery using innovative real-time tumor tracking and motion management technologies.

According to the company, this enables fast, accurate delivery of stereotactic radiosurgery for treating lesions, tumors, and conditions anywhere in the body where radiotherapy is indicated, including tumors of the lung, prostate, spine and brain.

Register
To receive FREE breaking news email alerts for Varian Medical Systems and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The Eurozone manufacturing moved closer to stagnation in September as German factory sector contracted for the first time in 15 months, final data from Markit Economics showed Wednesday. The manufacturing Purchasing Managers' Index fell more than intially estimated to a 14-month low of 50.3 from August's reading 50.7. The reading was below the earlier flash estimate of 50.5. Indonesia's inflation accelerated in September on food and utility costs, data from the Central Statistics Agency showed Wednesday. The trade balance swung into deficit in August as import growth exceeded the increase in exports. Inflation rose to 4.53 percent in September from 3.99 percent in... The U.K. economy grew more than estimated in the second quarter and the current account deficit widened from the first quarter, the Office for National Statistics said Tuesday. Gross domestic product grew 0.9 percent sequentially, up from the prior estimate of 0.8 percent. The annual growth was confirmed at 3.2 percent.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.